MisterBlues schreef op 13 augustus 2020 11:30:
Goede samenvatting interview Javit van een zeker Jesse (bedankt) op een ander forum.Some great points made during Dr Jonathan Javitt's interview this morning:
1) Next week, Houston Methodist hospital will provide update on critical ill patients and their outcomes. This is part of the Open Label study being done. He mentioned not to ruin the surprise but out of 5 patients on ECMO (Ventilators and very ill) 4 are alive. Dr Yosef to provide update next week.
2) Mentioned that in Brazil, doctors have already experience the great results on their patients from taking RLF 100
3) There is a new trial ready to start in September in regards to the INHALER form (VIP). They received FDA emergency designation on this.
4) No Safety Concerns on more than 100 patients that have been administered RLF 100. Not a single incident of adverse or safety concern with the drug.
5) Dr. Javitt met with the FDA last week and the outcome was a very positive scientific discussion.
6) Dr. Javitt is very connected and has the respect of the FDA based on his work and experience. He mentioned that his investigation drug application was approved by FDA within 48 hours when it can take weeks or months. He also mentioned that he requested to meet with the FDA. This usually takes up to 60 days to receive a response. He received response from FDA within 1 week.
7) RLF 100 is being administered in Houston, Miami, Kentucky, California. By the end of month should be at more than 10 hospitals.
8) Ready to announce a partnership with a BIG PHARMA for manufactured and distribution
9) We are about to receive an update by the Data Monitoring Committee on the trial taking place.
10) Provided evidence in X rays as to how the drug has helped critically ill patients go through a rapid recovery.